Physician profile
Sujit Itty
NPI 1699902577
$13,879.84
in general payments reported to CMS, 2019-2025
21 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $561 · 2020: $205 · 2021: $425 · 2022: $6,842 · 2023: $1,735 · 2024: $3,046 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,845.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,758.10 | 2022-2025 | |
| Alimera Sciences, INC. | $3,189.13 | 2020-2024 | Yutiq, Iluvien |
| Regeneron Healthcare Solutions, INC. | $1,137.87 | 2021-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $1,077.34 | 2019-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $401.68 | 2023-2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $400.12 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $395.86 | 2023-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $392.25 | 2022-2025 | Xipere, Visudyne, Retisert |
| Biogen, INC. | $299.63 | 2022-2024 | Byooviz |
| Dutch Ophthalmic, USA | $243.38 | 2019-2022 | |
| Allergan, INC. | $159.35 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $121.09 | 2019 | |
| Carl Zeiss Meditec, INC. | $69.76 | 2019 | |
| Ani Pharmaceuticals, INC. | $57.69 | 2025 | Purified Cortrophin Gel, Yutiq |
| Coherus Oncology, INC. | $36.68 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $34.02 | 2022-2025 | Unity |
| Horizon Therapeutics Plc | $24.44 | 2022 | |
| Harrow Eye, LLC | $23.58 | 2025 | Iheezo |
| Mallinckrodt Hospital Products INC. | $21.35 | 2022 | |
| Spark Therapeutics, INC. | $18.61 | 2021 | |
| Genentech, INC. | $17.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujit Itty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.